Aravive Analyst Ratings
Aravive Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/22/2023 | 21.95% | Cantor Fitzgerald | $18 → $0.25 | Downgrades | Overweight → Neutral |
| 08/03/2023 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 08/03/2023 | — | EF Hutton | Downgrades | Buy → Hold | |
| 08/03/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 08/03/2023 | — | BTIG | Downgrades | Buy → Neutral | |
| 07/21/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/17/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/10/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/03/2023 | 8680.49% | Cantor Fitzgerald | $18 → $18 | Reiterates | Overweight → Overweight |
| 06/05/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 06/05/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/25/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/25/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/17/2023 | 8680.49% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 05/11/2023 | 4778.05% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/11/2023 | 5753.66% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 03/16/2023 | 5753.66% | HC Wainwright & Co. | $7 → $12 | Maintains | Buy |
| 02/21/2023 | 3314.63% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/14/2023 | 4778.05% | EF Hutton | → $10 | Maintains | Buy |
| 01/05/2023 | 4778.05% | EF Hutton | → $10 | Initiates Coverage On | → Buy |
| 11/14/2022 | 875.61% | Piper Sandler | $6 → $2 | Maintains | Overweight |
| 10/25/2022 | 3314.63% | HC Wainwright & Co. | $26 → $7 | Maintains | Buy |
| 06/03/2022 | 7217.07% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
| 03/08/2021 | 12582.93% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 09/18/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/23/2020 | 12582.93% | HC Wainwright & Co. | $15 → $26 | Maintains | Buy |
| 03/27/2020 | 7217.07% | HC Wainwright & Co. | $25 → $15 | Maintains | Buy |
| 12/20/2019 | 12095.12% | HC Wainwright & Co. | $31 → $25 | Maintains | Buy |
| 12/10/2019 | 14534.15% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
| 11/20/2019 | 15021.95% | HC Wainwright & Co. | $18 → $31 | Reiterates | → Buy |
| 11/19/2019 | 17460.98% | Piper Sandler | $15 → $36 | Maintains | Overweight |
| 10/10/2019 | 8680.49% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
| 05/13/2019 | 4778.05% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 04/09/2019 | 6729.27% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/22/2023 | 21.95% | 坎託·菲茨傑拉德 | 18 美元 → 0.25 美元 | 降級 | 超重 → 中性 |
| 08/03/2023 | — | 威廉布萊爾 | 降級 | 跑贏大盤 → 市場表現 | |
| 08/03/2023 | — | EF Hutton | 降級 | 買入 → 持有 | |
| 08/03/2023 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 08/03/2023 | — | BTIG | 降級 | 買入 → 中性 | |
| 07/21/2023 | 8680.49% | 坎託·菲茨傑拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 07/17/2023 | 8680.49% | 坎託·菲茨傑拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 07/10/2023 | 8680.49% | 坎託·菲茨傑拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 07/03/2023 | 8680.49% | 坎託·菲茨傑拉德 | 18 美元 → 18 美元 | 重申 | 超重 → 超重 |
| 06/05/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 購買 → 購買 |
| 06/05/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 購買 → 購買 |
| 05/26/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 購買 → 購買 |
| 05/26/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 購買 → 購買 |
| 05/25/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 購買 → 購買 |
| 05/25/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 購買 → 購買 |
| 05/17/2023 | 8680.49% | 坎託·菲茨傑拉德 | → 18 美元 | 重申 | 超重 → 超重 |
| 05/11/2023 | 4778.05% | EF Hutton | → 10 美元 | 重申 | 購買 → 購買 |
| 05/11/2023 | 5753.66% | HC Wainwright & Co. | → 12 美元 | 重申 | 購買 → 購買 |
| 03/16/2023 | 5753.66% | HC Wainwright & Co. | 7 美元 → 12 美元 | 維護 | 購買 |
| 02/21/2023 | 3314.63% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 02/14/2023 | 4778.05% | EF Hutton | → 10 美元 | 維護 | 購買 |
| 01/05/2023 | 4778.05% | EF Hutton | → 10 美元 | 啓動覆蓋開啓 | → 購買 |
| 11/14/2022 | 875.61% | 派珀·桑德勒 | 6 美元 → 2 美元 | 維護 | 超重 |
| 10/25/2022 | 3314.63% | HC Wainwright & Co. | 26 美元 → 7 美元 | 維護 | 購買 |
| 06/03/2022 | 7217.07% | 羅斯資本 | → 15 美元 | 啓動覆蓋開啓 | → 購買 |
| 2021 年 8 月 3 日 | 12582.93% | BTIG | → 26 美元 | 啓動覆蓋開啓 | → 購買 |
| 09/18/2020 | — | 威廉布萊爾 | 啓動覆蓋開啓 | → 跑贏大盤 | |
| 2020 年 7 月 23 日 | 12582.93% | HC Wainwright & Co. | 15 美元 → 26 美元 | 維護 | 購買 |
| 2020 年 3 月 27 日 | 7217.07% | HC Wainwright & Co. | 25 美元 → 15 美元 | 維護 | 購買 |
| 12/20/2019 | 12095.12% | HC Wainwright & Co. | 31 美元 → 25 美元 | 維護 | 購買 |
| 2019 年 10 月 12 日 | 14534.15% | 坎託·菲茨傑拉德 | → 30 美元 | 啓動覆蓋開啓 | → 超重 |
| 2019 年 11 月 20 日 | 15021.95% | HC Wainwright & Co. | 18 美元 → 31 美元 | 重申 | → 購買 |
| 11/19/2019 | 17460.98% | 派珀·桑德勒 | 15 美元 → 36 美元 | 維護 | 超重 |
| 10/10/2019 | 8680.49% | HC Wainwright & Co. | → 18 美元 | 啓動覆蓋開啓 | → 購買 |
| 2019 年 5 月 13 日 | 4778.05% | 派珀·桑德勒 | → 10 美元 | 啓動覆蓋開啓 | → 超重 |
| 2019 年 9 月 4 日 | 6729.27% | Wedbush | → 14 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
What is the target price for Aravive (ARAV)?
Aravive (ARAV) 的目標價格是多少？
The latest price target for Aravive (NASDAQ: ARAV) was reported by Cantor Fitzgerald on August 22, 2023. The analyst firm set a price target for $0.25 expecting ARAV to rise to within 12 months (a possible 21.95% upside). 24 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年8月22日公佈了Aravive（納斯達克股票代碼：ARAV）的最新目標股價。該分析公司將目標股價定爲0.25美元，預計ARAV將在12個月內上漲至21.95％（可能上漲21.95％）。去年有24家分析公司公佈了評級。
What is the most recent analyst rating for Aravive (ARAV)?
分析師對Aravive（ARAV）的最新評級是多少？
The latest analyst rating for Aravive (NASDAQ: ARAV) was provided by Cantor Fitzgerald, and Aravive downgraded their neutral rating.
坎託·菲茨傑拉德提供了Aravive（納斯達克股票代碼：ARAV）的最新分析師評級，Aravive下調了中性評級。
When is the next analyst rating going to be posted or updated for Aravive (ARAV)?
Aravive（ARAV）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aravive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aravive was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與Aravive的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Aravive的最後一次評級是在2023年8月22日提交的，因此你應該預計下一個評級將在2024年8月22日左右公佈。
Is the Analyst Rating Aravive (ARAV) correct?
分析師評級 Aravive (ARAV) 正確嗎？
While ratings are subjective and will change, the latest Aravive (ARAV) rating was a downgraded with a price target of $18.00 to $0.25. The current price Aravive (ARAV) is trading at is $0.21, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Aravive（ARAV）評級已下調，目標股價爲18.00美元至0.25美元。Aravive（ARAV）目前的交易價格爲0.21美元，超出了分析師的預測區間。